You are on page 1of 13




"It is part of the cure to wish to be cured."

Seneca, Roman philosopher




Table of Contents....................................................................................................................2 What is The Robert Ryan Protocol........................................................................................................4 How It Works...........................................................................................................................5 Quality of Life..........................................................................................................................6 A Resource For The Cancer Patient.........................................................................................7 Family and Friend Support Networks.......................................................................................9 The Future of Cancer Research and Treatment.....................................................................10 Executive Summary of Viratech Corp....................................................................................10 Our Products......................................................................................................................11 Website Advertising and Sponsorships ..............................................................................12 Potential Market.................................................................................................................12



CANCER.IM? ( is the worlds first experienced-based social network resource site for cancer patients, survivors, advocates, and volunteers and is operated by Viratech Corp, the first open source biotech research social network platform. Most of the worlds most deadly cancers have a survival rate of less than 10% in 5 years. With early detection, and Cancer.ims help, it is Viratechs goal to help increase the survival rate to over 90% in 5 years with early detection and new complimentary ways to prevent and treat cancer. I am excited about this because every cancer survivor has a unique story to tell. The hindsight and experiences of those who have already been there are invaluable to patients currently battling the disease. Members of the network can find survivors who have lived through a specific type and stage of cancer. They can learn from these survivors what to expect, states Dr. Kevin Buckman, CEO of Viratech. Cancer.ims mission is to empower every cancer patient, regardless of their ability to pay, with the ability to research their disease and to find, organize, and manage their own cancer support network. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. strives to convert this saved energy into a higher level of patient activity and a stronger determination to fight. Unlike other social networks, was designed by a team that is dedicated to specifically serve the unique needs of those currently struggling with the disease. This new network combines databases of medical community knowledge, repositories of wisdom from cancer survivors, systems for helping cancer patients organize their records and various facets of their treatment, and tools that allow patients and their supporters to work together effectively. In short, provides everything a cancer patient, friend, or family member is looking for to help in the fight against the disease, all in one online location and easy-to-use format. is more than just another social network. It endeavors to provide all the tools necessary for cancer patients to maintain a high quality of life during treatment, and maintain a strong network of supporters. The resources on the site are designed to enable members to remain organized and informed, while becoming empowered patients. The networks ultimate goal is, by all these means, to maximize every patients opportunity to become a cancer survivor.


Leveraging the EORTC (European Organization for the Research and Treatment of Cancer) QLQ-30 index and social networking advancements, the Robert Ryan Cancer Protocol is the engine behind It is based on the work of Dr. Nico Nikolaou. On October 27, 2007 Dr. Nikolaou, on behalf of Fox Chase Medical Center (a National Comprehensive Cancer Network) published a double blind placebo controlled study titled Quality of Life (QOL) Supersedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC). The study was designed to evaluate the role of QoL as a prediction for survival. Some 91 percent of patients completed a standardized QoL survey before treatment. All patients were followed for at least 17 months. What they found is quality of life emerged as the most significant predictor of overall patient survival. We conducted two different statistical analyses including all the usual prognostic factors and either way, quality of life remained the strongest predictor of overall survival,Whats more, if a patients quality of life increased over time, we saw a corresponding increase in survival, Dr. Benjamin Movsas of Henry Ford Hospital This study concluded that by raising a Cancer Patients Quality of Life via the European Organization for Research and Treatment of Cancer QLQ-C30, you could directly lower the incidence of morbidity in a cancer patient, regardless of treatment. As is substantiated by a Fox Chase medical study, by raising the quality of life of the cancer patient, we can lower the incidence of morbidityregardless of treatment. The fifteen best-practice modules featured on the website assist in engaging friends and family to take some of the burden off of patients shoulders, while simultaneously allowing cancer patients to tap into cancer survivors' experiences. Through this unique approach, friends and family can move from a state of being helpless to one that is helpful, and cancer patients are empowered to fight their disease not from a state that is hopeless, but rather one that is hopeful. They can create their own customized strategy to fight their own cancer, based on their own values, beliefs, and resources, states Dr. Buckman. This Rosetta Stone study was the first time that a qualitative measure (Quality of Life) was validated in an evidenced based medicine study to have true medical benefit.

EORTC and the QLQ-30

The European Organization for Research and Treatment of Cancer (EORTC) was founded in 1962, as an international non-profit organization. The aims of the EORTC are to conduct, develop, coordinate and stimulate cancer research in Europe by

multidisciplinary groups of oncologists and basic scientists. Research is accomplished mainly through the execution of large, prospective, randomized, multi-centre, cancer clinical trials. The EORTC Central Office Data Center, created in 1974, is concerned with all aspects of Phase II and Phase III cancer clinical trials, from their design to the publication of the final results. Since its inception, over 80,000 patients have been entered in trials handled by the EORTC Data Center. In 1980, the EORTC created the Quality of Life Group, which in 1986 initiated a research program to develop an integrated, modular approach for evaluating the QoL of patients participating in cancer clinical trials. This led to the development of the EORTC QLQ-C30, a quality of life instrument for cancer patients. To date, more than 2,200 studies using the QLQ-C30 have been registered. The EORTC and the QLQ-30 Index is the gold standard that is used in all evidence based medicine studies as the qualitative link to the quantitative evidence based on the study. Sample questions include: Do you have trouble doing strenuous activities? Do you need to stay in bed or a chair during the day? Were you limited in doing either your work or other daily activities? Were you limited in pursuing your hobbies or other leisure time activities? Did you feel tense? Did you worry? Did you feel irritable? Did you feel depressed? Has your physical condition or medical treatment interfered with your family life? Has your physical condition or medical treatment interfered with your social activities? Has your physical condition or medical treatment caused you financial difficulties? How would you rate your overall quality of life during the past week? The incidence of morbidity is the American Cancer Society's fiscal analysis of survivability of a specific type and stage of cancer. As an example, a patient with stage four cholangiocarcinoma (liver cancer) is given a 3% chance of surviving. In the observation of the Robert Ryan protocol, the cancer patients who chose to be proactive were the 3% survivors.

HOW IT WORKS is, in its simplest form and fashion, 15 modules, based on the QLQ-30, that leverage social networking to provide information to the patient and support network. By using the experience of cancer survivors, and allowing people to research the disease, the patient can develop their own customized treatment strategy based on their values, beliefs, and resources. By taking matters into their own hands, patients develop confidence. And cancer patients who have confidence in the treatment do better than cancer patients that do not. Studies also show that

the survivors who decide to share their wisdom actually have a higher rate of surviving than cancer patients that do not, based on a Susan Coleman Foundation study in the 1980s. What and Viratech has done is take best practices and put them into a social network that shows the patient how to fight the disease and the support network what they can do to assist their loved on in the battle. The number one and two anxieties of cancer patients are dying and losing control, in that order. lowers the anxiety of the patient by providing a sense of control and a sense of community. He or she does not feel alone. They also control the community so that is made up entirely of positives. is a one way conversation. It allows the patient to have control over who sees what information, who has access to treatment plans, and what the public can see. It can do things as simple as help coordinate rides to doctor appointments, or arrange a meal. One of the benefits of is sharing knowledge. The goal is to turn a cancer patient into a cancer survivor. Sharing knowledge that is helping beat the disease is one more positive facet of control. If the patient does not want to have a person as part of their network, they can deny access. Through control like this, the community can be made of solely positive people and experiences, which improves the patients quality of life.




The vision that led to the creation of was the desire to increase cancer patients quality of life. Research has shown what most people involved in cancer treatment have long known intuitively, that increasing patient quality of life results in a drop in morbidity. One of the most important factors in improving quality of life for a patient is having an active support network. Clinical studies have confirmed that those cancer patients with an active support network of friends, family and other advocates outlive those who do not.'s networking tools empower every cancer patient to take control of their treatment by giving them ways to find, organize and manage their own cancer support network. Why is this so important? When someone is diagnosed with cancer, they feel as if their world is being turned upside down. This is to be expected. For the majority of people, they will start going to this doctor and that doctor, and feel as if they are becoming a statistic. They are as more of a science project than a person. The worth someone feels about themselves is taking a hard hit every time a doctor talks to that person as if they are the disease itself, not a person.

The first thing that most cancer patients do when they find out the news that they have cancer is visit some sort of time table for their specific kind of cancer. They look at the recovery percentage as well as how long they can live with the cancer. Each case of cancer, even of same or similar types, affects each person differently. These charts ultimately create unproductive and hope-reducing worry, diminishing the patients quality of life. When the quality of life is gone from a person who has cancer, the chances of their survival greatly decreases. Why is that? When they stop believing in themselves and start to see themselves as a statistic instead of person, they lose the will to fight. After all, who has the will to fight when the doctor says that 70% of those with this type of cancer do not make it? The patient may start to believe the fight wont be worth the predetermined outcome. Through participation in a support group that is going through or has been through the same type of cancer, the person can understand their illness fully. They are able to make decisions confidently because they have the opportunity to look it over with those that have been in their shoes. Having the ability to talk with someone who has been through what the patient is currently going through gives the person hope that they too can beat the odds and not become another statistic.


Cancer patients, when they begin to research their disease, suddenly find themselves awash in a sea of information. Personal research can produce as many questions as it produces answers. This can create increased anxiety in cancer patients, make them feel confused, and generate a sense that they are losing control over the treatment of their disease. To break this cycle, has amassed the largest Portal Indexed Cancer Research Database currently available online. This Portal Indexed Research Database was created to offer information on each of the more than 62,000 different aspects of cancer research. These aspects are not simply medical descriptions of types of cancer. They include treatment strategies, alternative medicines, clinics specializing in certain cancers or treatment approaches, oncologists and their specialties, recommended diets and exercise programs, and proven and experimental cancer prevention strategies. There are also entries in the database capturing patients experiences with different doctors and medical centers, evaluating them not only from the perspective of results but also in terms of level and type of care. Research volunteers formed into Micro Social Networks (MSNs) are tasked with helping members understand and research any and all of these different aspects of cancer. Network members can subscribe to receive information on cancer research and have a volunteer respond to their request with their findings.

As with any major life event, cancer brings paperwork. Patients can feel overwhelmed by the sheer quantity of health records, medical bills, insurance forms and claims to be filed for which they are now responsible. Treatment for cancer may also involve a major rethinking of home finances, since it may bring with it a loss of one or more income streams in addition to the new expenses of cancer treatment. has partnered with two leading Electronic Health Record (EHR) companies to help every member organize their health information. Members who have all their health information just a few keystrokes away also have an increased sense of control over their treatment, a correspondingly higher sense of well-being, and lower anxiety. All health records stored with are kept under tight security and accessible only by the member. The social networking aspect of can also help members with their financial needs, especially organizing and filing claims for health insurance and government assistance. Members may encounter difficulty working with insurance companies or in understanding their claims processes. Some may not know whether they qualify for Social Security assistance, or how to go about applying if they do. Volunteers and charitable organizations on the network are ready to provide direction and, if necessary, serve as advocates for the member with their insurance company or with government agencies. These advocacy individuals and groups have the experience of working with thousands of other cancer patients on these cases. Working with them can help a cancer patient understand that any paperwork problems they are encountering are not unique to them, and that they need not feel alone in dealing with them. On the road to recovery it is imperative for every cancer patient to remain proactive in their treatment, and maintain a sense of being in control. This is a critical aspect to maintaining a high quality of life. includes the tools to help patients develop their own Mission Adaptive Plan, or MAP. These MAPs are put together based on the input of oncologists and other cancer survivors and advocates. A MAP is a 16 step program of best practices which allows patients to craft a customized treatment strategy based on their own educated beliefs, values, and resources. Some of the steps that are part of the MAP creation process are: 1) Accepting the diagnosis of cancer, and realizing that dealing with it is more productive and healthier than denying it. While this may seem like an obvious step in the cancer treatment process, research has shown that it may be one of the most difficult to complete. The sooner cancer patients are able to accept their situation, the sooner they will be able to become involved in the treatment process. 2) Identifying and building a relationship with a sponsor. This sponsor will be someone who has already been treated for the patients form of cancer, and who can help them walk through the treatment process. The friends and family of a cancer patient may know them best as persons, and be able to offer moral support.

But a sponsor can share the experiences associated with being treated for the cancer itself. 3) Finding an oncologist, treatment center, or clinic, using a database complete with ratings and reviews from other cancer survivors. Who better to evaluate the level of care and competency of a doctor or center than one who has already used their services? 4) Help adopting an exercise program appropriate to the members treatment regimen, and assistance in creating a healthy diet with the nutrients necessary to counterbalance the treatment being undergone. 5) Researching medications and evaluating them for interactions. Negative drug interactions cause more than 100,000 deaths in the United States each year, ranking as the 4th highest cause of death. encourages members to register the medications they are on, and provides the tools necessary to evaluate them for adverse interactions. 6) Encouragement for members to become sponsors themselves, and share their insights and wisdom in the form of video interviews. realizes not all members will have a computer or know how to use one. The MAP is broken down into 16 printable sections, each of which represents step. Now cancer patients can take their research findings to doctors appointments for explanation, or read new research at their leisure apart from a computer screen. Members of a patients support network who are computer literate may help them develop their own MAP and print it. These same advocates may be encouraged to create their own MAP as a proactive cancer prevention strategy. Many cancer survivors find themselves burdened by having to repeat their stories several times, either to friends and family or to other cancer patients. enables survivors to record their stories for the benefit of future generations without having to personally repeat them. A standard set of interview questions has been developed that can be asked of every cancer survivor. Every answer to a question in the set results in a 30 to 60 second video clip. These clips then become part of a searchable database, or VIEW, which stands for Video Indexed Encapsulated Wisdom. The VIEW can be searched by the demographics of the survivor their age and sex, for example the type of cancer, and by any important keywords used in the video.




Friends, family, and other advocates are one of the most valuable support tools available to a cancer patient. allows patients to establish and enable their support network. For patients, this can mean something as simple as being able to send one email to communicate with their entire network, and as complex

as scheduling supporters who have offered to provide food after chemotherapy sessions. On the side of a patients friends and family, it is often difficult to know what help to offer or what to say to someone dealing with cancer. Feelings of helplessness can set in, and supporters can withdraw from a patient just when they are most needed. The networking tools provided by can be used to encourage supporters to remain active. They can allow patients to communicate more effectively with their friends and family about their current condition, their treatment progress and schedule, their needs, and their thanks. Support network members can know exactly how to contribute to a patients well-being, and the patient can avoid duplication of efforts among their advocates.






This method also offers a new way to conduct clinical trials much faster, with more access to new solutions, and more participants using Viratechs Social Network Platform, joint ventures, Open Source Cancer Research, and more awareness of these opportunities. By working with in this merger we can co-create power weapons against cancer, states Dr. Buckman. He adds, We are also working on solutions for early cancer detection, ways to find the underlying problems associated with cancer, and better ways to treat and monitor this disease. Using open source cancer research along with our social network platforms, we can together make a difference for cancer. There is an old proverb that says knowledge is power. To further empower patients and thereby increase their quality of life, a set of specific knowledgebuilding tools was developed to be a seamless part of These knowledgebuilding tools make much more than a traditional online network consisting only of groups, event calendars, and personal profiles. These tools allow members to: Learn from the wisdom of other cancer survivors through video clips; Research all aspects of cancer; Organize medical records, insurance, and research; Create a customized treatment strategy based on education, beliefs, and resources; and Develop a proactive cancer prevention strategy.




Viratech Corp. is a publicly held Nevada corporation, whose common stock trades on the OTC Markets Group, Inc. Pink Sheets (the Pink Sheets) under the trading

symbol, VIRA. Viratech is the first open source biotech research social network platform, with the goal of accelerating the research and development of new cancer therapies and diagnostics. Founded by Dr. Kevin Buckman and utilizing a process that protects intellectual property via social networking, Viratechs plan of operations is to consolidate the highly fragmented world of biotech research and development. During the last thirty years Dr. Buckman has worked to advance a number of medical technologies with a focus on the underlying causes of medical conditions, the early detection of disease and pre-disease, new solutions for preventive medicine, and has created non-harmful new methods of medical treatment. Viratech is an open source biotech research and development network leveraging both our social collaborative website and our intellectual property suite to provide a platform encouraging the sharing of biotech research for the sake of accelerating the development of new therapies and diagnostic procedures. Our toolsets fulcrum is a method of protecting intellectual property via social collaboration. Social networking activity and user generated content combine to form a mechanism of converting patents and other intellectual property into indexable expressions of a copyright work product. Using our toolset, members of the Viratech community can protect their intellectual property. It allows them the freedom to post their research and solicit collaboration and assistance from other members. It also allows them to broadcast what they need to develop and move their research into commercial production via press releases and social media distribution. Our second toolset focuses around crowdfunding. This is a means for companies requiring early stage research and development capital to get the funding to conduct research and the financing to prove the treatment/diagnostic efficacy. The Company believes that out intellectual property toolset within our social networking infrastructure has the potential of opening up the scientific community to share and collaborate on ideas, theories and know-how to streamline the development of new therapies and diagnostics within the cancer research community.

Our open source biotech development platform will be an interactive online community dedicated to serving the specific needs of cancer researchers and their counterparts. The site focuses on removing obstacles the researchers will encounter in taking ideas and theories to development and commercialization. The goal of the platform is to create a community of the greatest minds in cancer research who can


feel safe knowing their intellectual property is being safeguarded and can start to open up about new ideas and theories pertaining to the life sciences.




The Company expects its largest source of revenue to be from website advertisement and sponsorship sales. Advertising and sponsorship fees and rates will vary depending on page, placement, and size of the advertisement on the website. Premium fees will be charged for home page and section sponsorships while a lesser fee will apply to run scheduled advertisements which continuously rotate throughout the website. The Company anticipates that manufacturers of cancer-specific pharmaceuticals, products, and services will make up a large percentage of advertisement and sponsorship sales. However, the Company is promoting its advertising to a broad base of industries, including companies in the consumer products, travel, tourism, and other industries.

In the United States, it is estimated that there are more than 10 million cancer survivors. Worldwide, that figure is more than 24 million survivors. In the United States, just this year, 1.3 million people will be diagnosed with cancer for the first time and 556,000 people will die of the disease. This makes cancer the leading cause of death for people under the age of 85 years old. Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open source. Viratechs open source platform has integrated, via an exclusive license, several intellectual property tools which can provide our development partners a new intellectual property mechanism, which will help in addressing the following:

PROTECTION - Research and ideas are abstract, meaning without Intellectual Property
Protection any one can take them, use them and reap the rewards of commercial development. Intellectual property laws are archaic, and the process to protect and prosecute intellectual property claims is extremely expensive. An analysis by The World Intellectual Property Organization in Geneva confirms this and estimates that due to the high cost of intellectual property protection that only 47,000 patents or less than 1% of the estimated 4.73 million concepts annually seek a patent or patented protection The other 4,600,000 + ideas seek the only intellectual property protection they can afford, which is keeping it a trade secret or what we call closed source.

PROMOTION - If the only way you can protect your research is by making it a trade
secret, your ability to collaborate or generate business development is limited to the people and organizations who have signed a trade secret agreement.

Viratechs open source platform allows our development partners the ability of promoting their now protected intellectual property in a more public fashion. With a permission layer, owners can choose who gets to see what and when. They can broadcast results, press releases and ideas to the network for free.

PRODUCTION - The cost of developing an idea takes investment capital and

coordinating a team of experts from various fields. Traditionally this has been a highly fragmented process, and as such has been one of the hardest barriers of entry for the commercialization of a new technology. Viratechs open source platform has integrated via an exclusive license a crowdfunding tool which will allow our development partners newly protected and promoted technologies to offer an investment opportunity directly from their individual platform.